John S Spencer Selected Research

Paucibacillary Leprosy

12/2018	Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia.
8/2011	ML1419c peptide immunization induces Mycobacterium leprae-specific HLA-A*0201-restricted CTL in vivo with potential to kill live mycobacteria.
12/2005	Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy.
9/2005	Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John S Spencer Research Topics

Disease

29	Leprosy (Hansen's Disease) 01/2020 - 06/2004
14	Infections 01/2018 - 06/2004
12	Tuberculosis (Tuberculoses) 01/2018 - 06/2004
4	Paucibacillary Leprosy 12/2018 - 09/2005
3	Inflammation (Inflammations) 12/2017 - 09/2014
3	Lepromatous Leprosy 02/2013 - 06/2010
2	Communicable Diseases (Infectious Diseases) 10/2015 - 01/2013
2	Granuloma 09/2014 - 11/2007
2	Multibacillary Leprosy 12/2012 - 09/2005
2	Chronic Disease (Chronic Diseases) 12/2011 - 11/2007
1	Arteriosclerosis 12/2018
1	Cataract (Cataracts) 12/2018
1	Erythema Nodosum 12/2018
1	Osteoporosis 12/2018
1	Coinfection 01/2018
1	HIV Infections (HIV Infection) 01/2018
1	Asymptomatic Infections 01/2017
1	Parkinsonian Disorders (Parkinsonism) 01/2013
1	Tuberculoid Leprosy 12/2012
1	Disease Progression 12/2012
1	Congenital Abnormalities (Deformity) 12/2011

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 12/2017 - 06/2004
11	Proteins (Proteins, Gene)FDA Link 12/2017 - 06/2004
6	Biomarkers (Surrogate Marker)IBA 04/2019 - 05/2012
6	Peptides (Polypeptides)IBA 12/2017 - 06/2004
5	lipoarabinomannan (LAM)IBA 01/2018 - 02/2011
5	GlycolipidsIBA 01/2018 - 11/2006
5	AntibodiesIBA 01/2017 - 02/2011
5	Recombinant ProteinsIBA 02/2011 - 09/2005
3	EpitopesIBA 01/2018 - 06/2004
3	CytokinesIBA 09/2014 - 03/2009
3	Indicators and Reagents (Reagents)IBA 02/2013 - 12/2005
3	Glycoproteins (Glycoprotein)IBA 01/2013 - 06/2010
2	Immunoglobulin M (IgM)IBA 12/2018 - 12/2011
2	LipidsIBA 12/2018 - 12/2011
2	Polysaccharides (Glycans)IBA 01/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 12/2012 - 06/2010
2	Mycobacterium leprae phenolic glycolipid IIBA 12/2011 - 02/2011
2	Human Serum Albumin FDA LinkGeneric 12/2011 - 06/2010
2	DisaccharidesIBA 12/2011 - 06/2010
2	Interferon-gamma (Interferon, gamma)IBA 03/2009 - 09/2005
1	N 30IBA 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 12/2018
1	LipopolysaccharidesIBA 01/2018
1	arabinofuranoseIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	tuberculostearic acidIBA 01/2018
1	aluminum sulfate (alum)IBA 12/2017
1	insect maxadilan proteinIBA 12/2017
1	GoldIBA 01/2017
1	Mannose (D-Mannose)IBA 12/2016
1	Virulence Factors (Pathogenicity Factors)IBA 12/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2014
1	Interleukin-10 (Interleukin 10)IBA 09/2014
1	Subunit VaccinesIBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2013
1	TrisaccharidesIBA 12/2011
1	Oxygen (Dioxygen)IBA 11/2011
1	BuffersIBA 10/2011
1	AcidsIBA 02/2011
1	AzidesIBA 06/2010
1	Silk FDA Link 12/2009
1	EnzymesIBA 03/2008
1	AerosolsIBA 11/2007
1	ChemokinesIBA 11/2007
1	lymphotactinIBA 11/2007
1	VaccinesIBA 05/2007
1	Tuberculin (PPD)IBA 05/2007

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2014 - 11/2006